Literature DB >> 30452738

Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply.

Adam R Brentnall1, Diana S M Buist2, Jack Cuzick1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30452738      PMCID： PMC7098814          DOI： 10.1001/jamaoncol.2018.5102

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.

Authors:  Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

2.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

3.  Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling.

Authors:  Gaia Pocobelli; Jessica Chubak; Nancy Hanson; Charles Drescher; Robert Resta; Nicole Urban; Diana S M Buist
Journal:  Gynecol Oncol       Date:  2012-05-04       Impact factor: 5.482

4.  Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Authors:  Ranjit Manchanda; Shreeya Patel; Vladimir S Gordeev; Antonis C Antoniou; Shantel Smith; Andrew Lee; John L Hopper; Robert J MacInnis; Clare Turnbull; Susan J Ramus; Simon A Gayther; Paul D P Pharoah; Usha Menon; Ian Jacobs; Rosa Legood
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

5.  Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.

Authors:  Adam R Brentnall; Jack Cuzick; Diana S M Buist; Erin J Aiello Bowles
Journal:  JAMA Oncol       Date:  2018-09-13       Impact factor: 31.777

6.  Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.

Authors:  Jack Cuzick; Ivana Sestak; Simon Cawthorn; Hisham Hamed; Kaija Holli; Anthony Howell; John F Forbes
Journal:  Lancet Oncol       Date:  2014-12-11       Impact factor: 41.316
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.